T1	Intervention 38 96	oral JAK inhibitor tofacitinib (CP-690,550) versus placebo
T2	Intervention 117 140	background methotrexate
T3	Intervention 216 234	methotrexate alone
T4	Intervention 313 355	oral tofacitinib (CP-690,550) with placebo
T5	Intervention 463 481	methotrexate (MTX)
T6	Intervention 651 673	placebo or tofacitinib
T7	Intervention 835 839	MTX.
T8	Intervention 1030 1041	tofacitinib
T9	Intervention 2049 2060	tofacitinib